Literature DB >> 23213667

Transmission assessment surveys in the Global Programme to Eliminate Lymphatic Filariasis: WHO position statement.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23213667

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN： 0049-8114


× No keyword cloud information.
  10 in total

1.  Can malaria vector control accelerate the interruption of lymphatic filariasis transmission in Africa; capturing a window of opportunity?

Authors:  Louise A Kelly-Hope; David H Molyneux; Moses J Bockarie
Journal:  Parasit Vectors       Date:  2013-02-22       Impact factor: 3.876

2.  Are we nearly there yet? Coverage and compliance of mass drug administration for lymphatic filariasis elimination.

Authors:  Neal D E Alexander
Journal:  Trans R Soc Trop Med Hyg       Date:  2015-01-08       Impact factor: 2.184

3.  Identifying optimal threshold statistics for elimination of hookworm using a stochastic simulation model.

Authors:  James E Truscott; Marleen Werkman; James E Wright; Sam H Farrell; Rajiv Sarkar; Kristjana Ásbjörnsdóttir; Roy M Anderson
Journal:  Parasit Vectors       Date:  2017-06-30       Impact factor: 3.876

4.  Reaching endpoints for lymphatic filariasis elimination- results from mass drug administration and nocturnal blood surveys, South Gujarat, India.

Authors:  Anjali Modi; Sukesha Gamit; Bharat S Jesalpura; George Kurien; Jayendra K Kosambiya
Journal:  PLoS Negl Trop Dis       Date:  2017-04-03

5.  The Prevalence of Lymphatic Filariasis in Elementary School Children Living in Endemic Areas: A Baseline Survey Prior to Mass Drug Administration in Pekalongan District-Indonesia.

Authors:  Praba Ginandjar; Lintang Dian Saraswati; Dedy Suparyanto; Mateus Sakundarno; Taniawati Supali
Journal:  Iran J Public Health       Date:  2018-10       Impact factor: 1.429

6.  Step towards elimination of Wuchereria bancrofti in Southwest Tanzania 10 years after mass drug administration with Albendazole and Ivermectin.

Authors:  Jonathan Mnkai; Thomas F Marandu; Jacklina Mhidze; Agatha Urio; Lucas Maganga; Antelmo Haule; Godfrey Kavishe; Elizabeth Ntapara; Nhamo Chiwerengo; Petra Clowes; Sacha Horn; Maureen Mosoba; Wilfred Lazarus; Abdallah Ngenya; Akili Kalinga; Alex Debrah; Friedrich Rieß; Elmar Saathoff; Christof Geldmacher; Achim Hoerauf; Michael Hoelscher; Mkunde Chachage; Inge Kroidl
Journal:  PLoS Negl Trop Dis       Date:  2022-07-20

7.  Impact of six rounds of mass drug administration on Brugian filariasis and soil-transmitted helminth infections in eastern Indonesia.

Authors:  Taniawati Supali; Yenny Djuardi; Mark Bradley; Rahmah Noordin; Paul Rückert; Peter U Fischer
Journal:  PLoS Negl Trop Dis       Date:  2013-12-12

8.  Programmatic Use of Molecular Xenomonitoring at the Level of Evaluation Units to Assess Persistence of Lymphatic Filariasis in Sri Lanka.

Authors:  Ramakrishna U Rao; Sandhya D Samarasekera; Kumara C Nagodavithana; Manjula W Punchihewa; Tharanga D M Dassanayaka; Gamini P K D; Ethan Ford; Udaya S B Ranasinghe; Ralph H Henderson; Gary J Weil
Journal:  PLoS Negl Trop Dis       Date:  2016-05-19

9.  Evaluation of Lymphatic Filariasis and Onchocerciasis in Three Senegalese Districts Treated for Onchocerciasis with Ivermectin.

Authors:  Nana O Wilson; Alioune Badara Ly; Vitaliano A Cama; Paul T Cantey; Daniel Cohn; Lamine Diawara; Abdel Direny; Mawo Fall; Karla R Feeser; LeAnne M Fox; Achille Kabore; Amadou F Seck; Ngayo Sy; Daouda Ndiaye; Christine Dubray
Journal:  PLoS Negl Trop Dis       Date:  2016-12-07

10.  Safety and efficacy of co-administered diethylcarbamazine, albendazole and ivermectin during mass drug administration for lymphatic filariasis in Haiti: Results from a two-armed, open-label, cluster-randomized, community study.

Authors:  Christine L Dubray; Anita D Sircar; Valery Madsen Beau de Rochars; Joshua Bogus; Abdel N Direny; Jean Romuald Ernest; Carl R Fayette; Charles W Goss; Marisa Hast; Kobie O'Brian; Guy Emmanuel Pavilus; Daniel Frantz Sabin; Ryan E Wiegand; Gary J Weil; Jean Frantz Lemoine
Journal:  PLoS Negl Trop Dis       Date:  2020-06-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.